So far, no serious adverse effects have been reported from vaccine recipients, Sinopharm said Wednesday in an article on the social media platform WeChat, citing President Liu Jingzhen.
“In emergency use, we have now used it in nearly a million people. We have not received any reports of a serious adverse reaction, and only a few have some mild symptoms,” Liu said.
Liu said the vaccine had been administered to Chinese construction workers, diplomats and students who traveled to more than 150 countries around the world during the pandemic, and none of them have reported an infection.
He said on November 6 that there were 56,000 people who had received emergency vaccinations and then gone abroad.
“For example, a transnational company has 99 employees in one of its offices abroad, of which 81 were vaccinated.
“And then there was an outbreak in the office, 10 of the 18 people who were not vaccinated were infected and none of the vaccinated was infected,” he said.
He said that separately, Sinopharm had conducted phase 3 clinical trials involving nearly 60,000 people in 10 countries, including the United Arab Emirates, Bahrain, Egypt, Jordan, Peru and Argentina. CNN has not yet seen the results of these trials.
Sinopharm has two vaccine candidates. It is not clear which vaccine Liu was referring to.
Beijing has given companies approval for rush vaccines using experimental drugs for months.
In June, the Chinese company CanSino Biologics announced that it had been granted special authorization to administer its experimental vaccine to the People’s Liberation Army.
Since July, Chinese drugmakers have been administering experimental vaccines to people working in “high-risk” professions under the emergency use program, which allows vaccine candidates to be used on a limited scale before its safety and efficacy have been fully proven by clinical trials. .
Experimental coronavirus vaccines have even been reportedly offered to the public in parts of China, prompting some citizens to rush across the country to get a dose.
It comes after Pfizer announced the results of its phase 3 coronavirus vaccine trials on Wednesday, which it said were 95 percent effective in preventing infections, even in older adults, and caused no serious safety concerns.
A day earlier, Moderna announced that its coronavirus vaccine was 94.5 percent effective.
Pfizer is expected to apply for emergency use authorization from the US Food and Drug Administration for its vaccine on Friday.
Dr. Anthony Fauci, America’s leading infectious disease expert, said the Pfizer and Moderna vaccines had shown extraordinary efficacy.
“That is extraordinary,” Dr. Fauci said. “That’s almost at the level of what we see with the measles (vaccine), which is 98 percent effective.”